Hanseatic Management Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-400
Closed -$47.5K 134
2024
Q2
$47.5K Buy
+400
New +$50.6K 0.07% 76
2021
Q4
Sell
-2,320
Closed -$893K 165
2021
Q3
$893K Sell
2,320
-1,607
-41% -$593K 1.55% 12
2021
Q2
$923K Buy
3,927
+129
+3% +$23.1K 1.74% 10
2021
Q1
$497K Buy
3,798
+105
+3% +$15.2K 0.99% 30
2020
Q4
$386K Sell
3,693
-3,246
-47% -$328K 0.83% 41
2020
Q3
$491K Buy
6,939
+148
+2% +$10.3K 1.11% 14
2020
Q2
$436K Buy
+6,791
New +$372K 0.37% 87

Other funds holding MRNA

Hanseatic Management Services's MRNA Position: Q3 2024 in Review

Hanseatic Management Services sold out of Moderna (MRNA) in Q3 2024, closing a stake of 400 shares — an estimated $47.5K sold.

Hanseatic Management Services first reported a position in MRNA in Q2 2020 and held it in 7 quarters. The position peaked at $923K in Q2 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Hanseatic Management Services reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Hanseatic Management Services sold 400 Moderna shares in Q3 2024, an estimated $47.5K.
  • Hanseatic Management Services first reported a position in Moderna in Q2 2020 and held it in 7 quarters.
  • Hanseatic Management Services's Moderna position peaked at $923K in Q2 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Hanseatic Management Services's 13F filing for Q3 2024, filed 31 Oct 2024.